Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2010
03/18/2010US20100071090 Compositions and methods for expression of a heterologous nucleotide sequence in plants
03/18/2010US20100071089 Method For Increasing Pathogen Resistance In Transgenic Plants
03/18/2010US20100071086 Polysome-mediated cell type-, tissue type- or condition-enhanced transcript profiling
03/18/2010US20100071085 System for Expression of Genes in Plants from a Virus-Based Expression Vector
03/18/2010US20100071081 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours
03/18/2010US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis
03/18/2010US20100070186 Methods of screening for and mapping phenotypic and genotypic variations in cells
03/18/2010US20100069479 Neurodegenerative disease treatment using jak/stat inhibition
03/18/2010US20100069475 Method of activating nk cells
03/18/2010US20100069467 Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
03/18/2010US20100069465 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/18/2010US20100069462 Mitochondrial function of prohibitin 2 (phb2)
03/18/2010US20100069461 Compositions and methods for inhibiting expression of factor v leiden mutant gene
03/18/2010US20100069443 Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
03/18/2010US20100069442 Pyrazole compounds that modulate hsp90 activity
03/18/2010US20100069400 Methods for treating inflammation and related conditions
03/18/2010US20100069333 Alpha-helix mimetics and method relating to the treatment of cancer stem cells
03/18/2010US20100069331 Treatment or prevention of cancer and precancerous disorders
03/18/2010US20100069321 Biological Materials and Uses Thereof
03/18/2010US20100069306 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
03/18/2010US20100069297 Selective Inhibition of TLR4 Signaling
03/18/2010US20100069251 Methods for producing embryonic stem cells from parthenogenetic embryos
03/18/2010US20100068814 Multi-microrna methods and compositions
03/18/2010US20100068813 Apoptotic cell-mediated transfection of mammalian cells with interfering rna
03/18/2010US20100068812 Method for increasing transformation efficiency in plants, comprising coculture step for culturing plant tissue with coculture medium containing 3, 6-dichloro-o-anisic acid
03/18/2010US20100068811 Cardiac Stem Cells
03/18/2010US20100068810 Methods and compositions for growth of embryonic stem cells
03/18/2010US20100068809 Reproductive cell function preservation system
03/18/2010US20100068808 Tubular nanostructure targeted to cell membrane
03/18/2010US20100068807 INTERFERON-alpha REGULATOR
03/18/2010US20100068806 Novel methods and reagents directed to production of cells
03/18/2010US20100068805 Xeno-free culture conditions for human embryonic stem cells and methods thereof
03/18/2010US20100068804 Methods of stimulating expansion of hematopoietic stem cells
03/18/2010US20100068803 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
03/18/2010US20100068802 Novel human androgen receptor alternative splice variants as biomarkers and therapeutic targets
03/18/2010US20100068793 Devices and methods for production of cell aggregates
03/18/2010US20100068785 Spinosyn-producing polyketide synthases
03/18/2010US20100068763 Mammalian chemokines; receptors; reagents; uses
03/18/2010US20100068732 Cloned glucagon-like peptide-2 receptors
03/18/2010US20100068719 Cell culture system for determinging the sensitizing, allergenic and/or irritating effect of a substance
03/18/2010US20100068308 Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease
03/18/2010US20100068281 Methods and compositions for tissue regeneration
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068251 Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
03/18/2010US20100068245 Preparation and storage of stable, biologically active materials
03/18/2010US20100068241 Reconstituted mineralized cartilage tissue
03/18/2010US20100068226 Polynucleotides and Uses Thereof
03/18/2010US20100068215 Use of GDF traps to increase red blood cell levels
03/18/2010US20100068199 Pcsk9 antagonists
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100068193 Methods and materials for the generation of regulatory t cells
03/18/2010US20100068192 Method for Production of T Cell Population
03/18/2010US20100068190 Mesoangioblast-like cell as well as methods and uses relating thereto
03/18/2010US20100068189 Method for Expanding Adult Stem Cells from Blood and Compositions and Methods for Using the Same
03/18/2010US20100068188 Composition for regeneration of periodontal hard tissue and method for regeneration of periodontal hard tissue
03/18/2010US20100068187 Transcription factors for differentiation of adult human olfactory progenitor cells
03/18/2010US20100068186 High affinity telomerase t cell receptors
03/18/2010US20100068180 Novel methods for modulating inflammatory and/or immune responses
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068173 Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects
03/18/2010US20100068172 Nematode Control
03/18/2010US20100068150 Selective Caspase Inhibitors
03/18/2010US20100068144 Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
03/18/2010US20100068142 Melanoma repopulating cells
03/18/2010US20100068135 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
03/18/2010US20100067771 Energy resolved imaging
03/18/2010US20100066880 Microchip and method for cell sorting
03/18/2010CA2737193A1 Ischemic tissue cell therapy
03/18/2010CA2736851A1 System and method for producing t cells
03/18/2010CA2736488A1 Elimination of a contaminating non-human sialic acid by metabolic competition
03/18/2010CA2734968A1 Use of hsa-producing cells
03/18/2010CA2734922A1 Compositions comprising nfatc and ap-1 and methods using said compositions for protecting cells against hyperosmolality
03/18/2010CA2734189A1 Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof
03/18/2010CA2639943A1 Solanum bulbocastanum polyubiquitin promoter and uses thereof
03/17/2010EP2163895A1 A method for selecting mammal transformed cells
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
03/17/2010EP2163640A1 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
03/17/2010EP2163631A1 Expression cassettes for guard cell-preferential expression in plants
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163618A2 Fluorescent protein
03/17/2010EP2163614A1 Porcine animals lacking any expression of functional alpha 1, 3, galactosyltransferase
03/17/2010EP2163564A1 Cancerous disease modifying antibodies
03/17/2010EP2163562A2 IL-1beta binding antibodies and fragments thereof
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163560A2 Compositions and methods using RNA interference for control of nematodes in plants
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010EP2163243A1 Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
03/17/2010EP2162763A2 Dose profile measurement system for clinical proton fields
03/17/2010EP2162534A1 Cd34 stem cell-related methods and compositions
03/17/2010EP2162532A2 Tumour-cell-fixing cells
03/17/2010EP2162531A1 Method and means for culturing osteoblastic cells
03/17/2010EP2162530A1 Isolated proliferating cells with stem cell properties from adult tissue of poikilothermic vertebrates, stable cell cultures thereof, and method for their preparation
03/17/2010EP2162529A1 Selective cell therapy for the treatment of renal failure
03/17/2010EP1664300B1 A new class of a2delta calcium channel subunits
03/17/2010EP1636344B1 Pharmaceutically compatible method for purifying intact bacterial minicells
03/17/2010EP1556493B1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010EP1091971B1 Polyketide synthesis
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 1827